GO:0005462 UDP-N-acetylglucosamine transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005462 describes the molecular function of moving UDP-N-acetylglucosamine (UDP-GlcNAc) across a membrane, a step required for glycosylation reactions inside the secretory pathway.
• SLC35A3 is the best-characterized Golgi-resident UDP-GlcNAc transporter, and conserved residues such as Glu-47 and Lys-50 are essential for its UDP-GlcNAc/UMP antiport activity.
• SLC35G3 was recently identified as a UDP-GlcNAc transporter that supports sperm glycoprotein formation and male fertility in mice.
• The porcine SLC35A3 gene has been profiled for expression, chromosome assignment and mutational variation, linking this transporter to livestock traits.
• UDP-GlcNAc transport supports N-glycosylation and cell-surface regulation, processes that influence signaling, adhesion and stress responses.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools to test how GO:0005462-related genes control glycosylation and physiology.
Description
GO:0005462, UDP-N-acetylglucosamine transmembrane transporter activity, is a molecular function that enables the transfer of UDP-N-acetylglucosamine (UDP-GlcNAc) from one side of a membrane to the other. UDP-GlcNAc is a nucleotide sugar that serves as a donor substrate for glycosyltransferases, and its delivery into the lumen of the endoplasmic reticulum and Golgi apparatus is a prerequisite for many glycosylation reactions. Because glycosylation controls protein folding, stability, trafficking and cell-surface recognition, the transporters that supply UDP-GlcNAc are central to both basic cell biology and disease research. The best-studied member of this functional class is SLC35A3, a Golgi-associated UDP-GlcNAc transporter that operates as a UDP-GlcNAc/UMP antiporter. Mutational analysis of mouse Slc35a3 showed that conserved Glu-47 and Lys-50 residues are critical for this antiport activity, providing direct structure-function evidence for the transport mechanism. More recently, SLC35G3 was identified as a UDP-GlcNAc transporter required for sperm glycoprotein formation and male fertility in mice, expanding the physiological roles of this GO term beyond somatic glycosylation. For researchers, GO:0005462 matters because defects in nucleotide sugar transport can alter the glycosylation landscape of cells and organisms. The porcine SLC35A3 gene has been characterized for expression, chromosome assignment and mutational variation, showing that this transporter is also relevant to comparative and agricultural genetics. Studying this activity therefore connects molecular transport, glycobiology, reproduction and disease modeling.
UDP-N-acetylglucosamine transmembrane transporter activity At A Glance
| GO ID | GO:0005462 |
|---|---|
| GO term | UDP-N-acetylglucosamine transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | Transfers UDP-N-acetylglucosamine across a membrane to supply substrate for glycosylation |
| Representative gene | SLC35A3 (Golgi-resident UDP-GlcNAc/UMP antiporter) |
| Additional gene | SLC35G3 (UDP-GlcNAc transporter required for sperm glycoprotein formation) |
| Substrate | UDP-N-acetylglucosamine (UDP-GlcNAc) |
| Cellular context | Secretory pathway membranes, including Golgi and related compartments |
What Is GO:0005462?
In simple terms, GO:0005462 is the activity that carries UDP-N-acetylglucosamine across a biological membrane. The official definition states that it enables the transfer of a UDP-N-acetylglucosamine from one side of a membrane to the other, where N-acetylglucosamine is a structural unit of oligosaccharides linked to uridine diphosphate. This activity is a molecular_function in the Gene Ontology and is typically associated with membrane-embedded nucleotide sugar transporters that move UDP-GlcNAc into the lumen of the secretory pathway.
Why Is UDP-N-acetylglucosamine transmembrane transporter activity Important in Cell Biology?
GO:0005462 is important because UDP-GlcNAc is a central donor for glycosylation, and its transport into the secretory pathway determines whether proteins and lipids can be properly glycosylated. Glycosylation affects protein folding, cell-surface signaling, adhesion and immune recognition, so changes in UDP-GlcNAc transport can have broad cellular consequences. Genetic studies have linked this activity to male fertility through SLC35G3, and structure-function work on SLC35A3 has defined residues required for antiport. In addition, the porcine SLC35A3 gene has been analyzed for expression and mutations, indicating relevance to animal genetics and production traits.
• Supplies UDP-GlcNAc for N-glycosylation and other glycosylation reactions in the secretory pathway.
• Supports sperm glycoprotein formation and male fertility in mice through SLC35G3.
• Defines a conserved antiport mechanism in SLC35A3 that requires Glu-47 and Lys-50.
• Connects nucleotide sugar transport to cell-surface regulation and adaptive responses.
• Provides a target for comparative genomics, as shown by characterization of porcine SLC35A3.
• Enables CRISPR-based dissection of transporter function in glycosylation and reproduction.
• Relevant to congenital disorders of glycosylation when transport is disrupted.
• Offers a model for studying substrate specificity among nucleotide sugar transporters.
• Can be engineered in cell models to test glycosylation-dependent phenotypes.
• Links basic glycobiology to applied fields such as livestock genetics.
What Happens During UDP-N-acetylglucosamine transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs UDP-GlcNAc on one side of the membrane.
UDP-N-acetylglucosamine transmembrane transporter activity begins with recognition of UDP-GlcNAc as a substrate. In SLC35A3, conserved residues including Glu-47 and Lys-50 are critical for this process, as mutation of these residues impairs UDP-GlcNAc/UMP antiport activity. The transporter must distinguish UDP-GlcNAc from other nucleotide sugars, a specificity that has been studied in related nucleotide sugar transporters.
Translocation across the membrane
In simple terms: The transporter then moves UDP-GlcNAc through the membrane.
After binding, the transporter undergoes conformational changes that transfer UDP-GlcNAc from one side of the membrane to the other. This translocation step is the defining feature of GO:0005462 and is required to deliver UDP-GlcNAc into the lumen of the secretory pathway for glycosylation. The process is energy-independent in the sense that it uses an antiport mechanism rather than ATP hydrolysis.
Antiport with UMP
In simple terms: The transporter swaps UDP-GlcNAc for UMP in a two-way exchange.
SLC35A3 functions as a UDP-GlcNAc/UMP antiporter, meaning that UDP-GlcNAc entry is coupled to UMP exit. This exchange mechanism maintains the balance of nucleotide sugars and nucleoside monophosphates across the membrane. Mutational analysis has shown that Glu-47 and Lys-50 are essential for this antiport activity, providing mechanistic insight into the transport cycle.
Delivery for glycosylation
In simple terms: Once inside, UDP-GlcNAc is used to build sugar chains on proteins and lipids.
The UDP-GlcNAc delivered by this activity serves as a donor substrate for glycosyltransferases in the Golgi and endoplasmic reticulum. This supply is necessary for N-glycosylation and other glycosylation events that regulate protein folding, trafficking and cell-surface interactions. In sperm, SLC35G3-mediated UDP-GlcNAc transport supports glycoprotein formation required for male fertility.
Key Genes Involved in GO:0005462 UDP-N-acetylglucosamine transmembrane transporter activity
The following genes and proteins are directly or closely associated with UDP-N-acetylglucosamine transmembrane transporter activity (GO:0005462) based on published experimental evidence.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC35A3 | Golgi-resident UDP-GlcNAc/UMP antiporter | Defines the canonical mechanism of GO:0005462; conserved Glu-47 and Lys-50 are required for antiport |
| SLC35G3 | UDP-GlcNAc transporter for sperm glycoprotein formation | Required for male fertility in mice; links GO:0005462 to reproduction |
| SLC35A3 (porcine) | Golgi UDP-GlcNAc transporter in pig | Expression profiling, chromosome assignment and mutational analysis in livestock |
| SLC35A2 | UDP-galactose transporter that also transports UDP-GalNAc | Related nucleotide sugar transporter useful for comparative specificity studies |
| SLC35A1 | CMP-sialic acid transporter | Provides context for the broader nucleotide sugar transporter family |
| SLC35B1 | UDP-galactose/UDP-GlcNAc transporter | Related family member for comparative analysis |
| SLC35B4 | UDP-GlcNAc transporter | Potential alternative route for UDP-GlcNAc supply |
| SLC35C1 | GDP-fucose transporter | Family member relevant to glycosylation pathway context |
| SLC35D1 | UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter | Comparative model for substrate specificity |
| SLC35D2 | UDP-N-acetylglucosamine/UDP-glucose transporter | Related activity for studying substrate overlap |
| UGP2 | UDP-glucose pyrophosphorylase | Contributes to nucleotide sugar pools upstream of transport |
| GFPT1 | Glutamine--fructose-6-phosphate transaminase 1 | Rate-limiting enzyme for hexosamine pathway and UDP-GlcNAc synthesis |
| GFPT2 | Glutamine--fructose-6-phosphate transaminase 2 | Isoform contributing to UDP-GlcNAc production |
| OGT | O-GlcNAc transferase | Uses UDP-GlcNAc for O-GlcNAcylation; connects transport to signaling |
| MGAT1 | Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Golgi glycosyltransferase that consumes UDP-GlcNAc |
| B4GALT1 | Beta-1,4-galactosyltransferase 1 | Glycosyltransferase in the secretory pathway |
| ST6GAL1 | ST6 beta-galactoside alpha-2,6-sialyltransferase 1 | Sialyltransferase that depends on nucleotide sugar supply |
| B3GNT2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Consumes UDP-GlcNAc in poly-N-acetyllactosamine synthesis |
How Is UDP-N-acetylglucosamine transmembrane transporter activity Regulated?
The activity of UDP-N-acetylglucosamine transmembrane transporters is regulated at multiple levels. Expression of SLC35A3 has been profiled in different tissues and developmental stages, and mutational variation in the porcine gene suggests genetic regulation. At the protein level, conserved residues such as Glu-47 and Lys-50 are required for antiport function, so post-translational changes or mutations affecting these positions can alter activity. In addition, the demand for UDP-GlcNAc in the secretory pathway is coupled to the supply of nucleotide sugars, which is influenced by metabolic pathways and glycosylation load. SLC35G3 expression is required for sperm glycoprotein formation, indicating developmental and cell-type-specific regulation.
UDP-N-acetylglucosamine transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC35A3 | Glycosylation defects and congenital disorders of glycosylation | Knockout and point-mutation cell lines to test UDP-GlcNAc/UMP antiport |
| SLC35G3 | Male infertility and sperm glycoprotein formation | Knockout mouse and sperm glycoprotein analysis |
| SLC35A3 (porcine) | Livestock production traits and glycosylation variation | Porcine cell models and mutational analysis |
| GFPT1 | Hexosamine pathway and UDP-GlcNAc supply | Overexpression and knockout models to alter substrate availability |
| OGT | O-GlcNAcylation and signaling | Knockout and overexpression to link transport to signaling |
Congenital disorders of glycosylation and glycosylation defects
Disruption of nucleotide sugar transport can impair glycosylation and lead to congenital disorders of glycosylation, which affect multiple organ systems. Because GO:0005462 supplies UDP-GlcNAc for N-glycosylation, loss of transporter function may alter protein folding and cell-surface signaling. Experimental models with SLC35A3 mutations can help define how transport defects translate into glycosylation abnormalities.
Male infertility and reproductive biology
SLC35G3, a UDP-GlcNAc transporter, is required for sperm glycoprotein formation and male fertility in mice. Knockout of SLC35G3 impairs sperm function, linking GO:0005462 directly to reproductive phenotypes. This makes the transporter a potential target for studying male fertility and developing reproductive models.
Cancer and cell-surface glycosylation
Altered glycosylation is a hallmark of cancer, and UDP-GlcNAc transport supports the glycosylation machinery that builds tumor-associated glycans. Changes in nucleotide sugar transporter expression can affect cell adhesion, migration and signaling. Studying GO:0005462 in cancer models may reveal how glycosylation contributes to tumor progression.
Livestock genetics and production traits
The porcine SLC35A3 gene has been characterized for expression, chromosome assignment and mutations, indicating relevance to livestock traits. This comparative work shows that GO:0005462-related genes can be studied beyond human disease, with potential agricultural applications.
From UDP-N-acetylglucosamine transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SLC35A3 required for UDP-GlcNAc transport? | CRISPR knockout of SLC35A3 in Golgi glycosylation reporter cells |
| Which residues are essential for antiport? | Point mutations at Glu-47 and Lys-50 in SLC35A3 |
| Does SLC35G3 support sperm glycoprotein formation? | Knockout mouse and sperm glycoprotein analysis |
| Can tagged SLC35A3 be localized in cells? | Knock-in of fluorescent or epitope tags at the endogenous locus |
| Does overexpression of SLC35A3 alter glycosylation? | Overexpression cell lines and glycomics |
| Can UDP-GlcNAc transport be redirected to other sugars? | Knock-in or point-mutation models based on related transporters |
How to Study the UDP-N-acetylglucosamine transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive UDP-GlcNAc transport assay | Direct transport activity and antiport | Testing SLC35A3 mutants |
| Mass spectrometry glycomics | N-glycan and O-glycan structures | Linking transport to glycosylation |
| CRISPR knockout screen | Genes required for glycosylation or transport | Identifying modifiers of GO:0005462 |
| Fluorescence microscopy | Subcellular localization of transporters | Golgi localization of SLC35A3 |
| RNA-seq / qPCR | Expression levels across tissues | Profiling SLC35A3 and SLC35G3 |
| Lectin staining | Cell-surface glycan display | Assessing glycosylation changes |
| Sperm glycoprotein analysis | Glycoprotein composition in sperm | SLC35G3 fertility studies |
| Mutational analysis | Residues required for transport | Glu-47 and Lys-50 in SLC35A3 |
Transport assays with radioactive or fluorescent UDP-GlcNAc
Direct measurement of UDP-N-acetylglucosamine transmembrane transporter activity can be performed using radioactive or fluorescent UDP-GlcNAc in membrane vesicle or permeabilized cell assays. These assays quantify uptake or antiport and can be combined with mutant transporters to identify essential residues such as Glu-47 and Lys-50.
Glycosylation profiling by mass spectrometry
Mass spectrometry-based glycomics and glycoproteomics can measure how changes in UDP-GlcNAc transport affect N-glycan and O-glycan structures. This approach is useful for linking GO:0005462 to downstream glycosylation phenotypes in knockout or overexpression cells.
CRISPR screens and genetic analysis
CRISPR knockout screens can identify genes that modify UDP-GlcNAc transport or glycosylation-dependent phenotypes. Such screens can be combined with lectin staining or reporter assays to isolate transporters and glycosyltransferases.
Expression and localization imaging
Fluorescence microscopy of tagged transporters can reveal subcellular localization in the Golgi or other compartments. Expression profiling by RNA-seq or qPCR can show tissue-specific patterns, as demonstrated for porcine SLC35A3.
How CRISPR Can Be Used to Study GO:0005462 UDP-N-acetylglucosamine transmembrane transporter activity
Knockout
CRISPR knockout of SLC35A3 or SLC35G3 can eliminate UDP-N-acetylglucosamine transmembrane transporter activity and reveal downstream glycosylation defects. Knockout models are useful for testing whether a transporter is required for sperm glycoprotein formation or for general N-glycosylation.
Point Mutation
Point mutations at conserved residues such as Glu-47 and Lys-50 in SLC35A3 can dissect the antiport mechanism without deleting the entire protein. These models help distinguish transport activity from other functions of the protein.
Knock-in
Knock-in of tags or reporter sequences at the endogenous SLC35A3 or SLC35G3 locus allows real-time localization and expression analysis. Tagged knock-in models can also be used to study protein trafficking in the secretory pathway.
Overexpression
Overexpression of UDP-GlcNAc transporters can increase substrate supply to the Golgi and alter glycosylation patterns. Such models are useful for testing whether increased transport is sufficient to change cell-surface glycan display.
How EDITGENE Supports UDP-N-acetylglucosamine transmembrane transporter activity Research
Researchers studying UDP-N-acetylglucosamine transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in glycosylation, fertility or disease. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly, from knockout to precise point mutations and tagged knock-ins.
Contact EDITGENE today to design your custom CRISPR model for UDP-N-acetylglucosamine transmembrane transporter activity research.
Frequently Asked Questions About UDP-N-acetylglucosamine transmembrane transporter activity
What is UDP-N-acetylglucosamine transmembrane transporter activity?
It is the molecular function defined by GO:0005462 that moves UDP-N-acetylglucosamine across a membrane, supplying substrate for glycosylation.
What genes are involved in UDP-N-acetylglucosamine transmembrane transporter activity?
Key genes include SLC35A3, a Golgi UDP-GlcNAc/UMP antiporter, and SLC35G3, a transporter required for sperm glycoprotein formation.
What is the GO ID for UDP-N-acetylglucosamine transmembrane transporter activity?
The GO ID is GO:0005462.
Which residues are important for SLC35A3 transport activity?
Conserved Glu-47 and Lys-50 residues are critical for UDP-GlcNAc/UMP antiport activity in mouse Slc35a3.
How is UDP-N-acetylglucosamine transport linked to male fertility?
SLC35G3-mediated UDP-GlcNAc transport supports sperm glycoprotein formation, and its loss impairs male fertility in mice.
What diseases are associated with defects in UDP-GlcNAc transport?
Defects can contribute to congenital disorders of glycosylation and altered cell-surface glycosylation relevant to cancer.
How can I study UDP-N-acetylglucosamine transmembrane transporter activity in the lab?
Common methods include radioactive transport assays, glycomics, CRISPR knockout and point-mutation models, and imaging of tagged transporters.
Is SLC35A3 the only UDP-N-acetylglucosamine transporter?
No, SLC35G3 has also been identified as a UDP-GlcNAc transporter, and other family members may contribute to transport.
What is the difference between SLC35A3 and SLC35G3?
SLC35A3 is a Golgi-resident UDP-GlcNAc/UMP antiporter, while SLC35G3 is required for sperm glycoprotein formation and male fertility.
Can CRISPR be used to study UDP-N-acetylglucosamine transport?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are used to dissect transporter function and glycosylation phenotypes.
Conclusion
GO:0005462, UDP-N-acetylglucosamine transmembrane transporter activity, is a fundamental molecular function that supplies UDP-GlcNAc for glycosylation in the secretory pathway. SLC35A3 and SLC35G3 are key genes that illustrate its mechanism and physiological importance, from antiport residues to male fertility. Understanding this activity helps explain how glycosylation is controlled and how its disruption contributes to disease and reproductive phenotypes. CRISPR-based models, combined with transport assays and glycomics, provide a robust toolkit for studying GO:0005462 and its downstream effects. EDITGENE supports this research with knockout, point-mutation, knock-in, overexpression and screening services tailored to UDP-GlcNAc transporter biology.
References
- 1. Mashiko D et al.. 2025. SLC35G3 is a UDP-N-acetylglucosamine transporter for sperm glycoprotein formation and underpins male fertility in mice.. Elife 14 PMID: 41222000
- 2. Toscanini MA et al.. 2019. Conserved Glu-47 and Lys-50 residues are critical for UDP-N-acetylglucosamine/UMP antiport activity of the mouse Golgi-associated transporter Slc35a3.. J Biol Chem 294(26):10042-10054 PMID: 31118275
- 3. Mashiko D et al.. 2025. SLC35G3 is a UDP-N-acetylglucosamine transporter for sperm glycoprotein formation and underpins male fertility in mice.. bioRxiv PMID: 40462929
- 4. Andersen PK et al.. 2007. Gene expression profiling, chromosome assignment and mutational analysis of the porcine Golgi-resident UDP-N-acetylglucosamine transporter SLC35A3.. Mol Membr Biol 24(5-6):519-30 PMID: 17710655
- 5. Dennis JW et al.. 2009. Adaptive regulation at the cell surface by N-glycosylation.. Traffic 10(11):1569-78 PMID: 19761541
- 6. Segawa H et al.. 2002. Human and Drosophila UDP-galactose transporters transport UDP-N-acetylgalactosamine in addition to UDP-galactose.. Eur J Biochem 269(1):128-38 PMID: 11784306
